Ancora Advisors LLC - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 68 filers reported holding NOVELION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$15,000
-79.2%
4,911
-78.8%
0.00%
-75.0%
Q4 2017$72,000
-92.6%
23,137
-83.4%
0.00%
-93.0%
Q3 2017$979,000
-79.1%
139,261
-72.6%
0.06%
-81.2%
Q2 2017$4,688,000
-13.7%
507,981
+0.4%
0.30%
-17.4%
Q1 2017$5,433,000
+15.1%
505,911
-9.8%
0.37%
+7.0%
Q4 2016$4,721,000560,6130.34%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,703,420$2,685,0002.61%
Healthcare Value Capital, LLC 1,400,000$1,015,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 581,042$421,0000.06%
KNOTT DAVID M 109,135$79,0000.03%
EdgePoint Investment Group Inc. 3,100,931$2,248,0000.02%
Yakira Capital Management, Inc. 36,428$26,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$33,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,353$61,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 19,814$14,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders